Your browser doesn't support javascript.
loading
Ovarian adrenal rest tumor in congenital adrenal hyperplasia: Is medical treatment the first line option?
Koren, Ronit; Koren, Shlomit; Khashper, Alla; Benbassat, Carlos; Pekar-Zlotin, Marina; Vaknin, Zvi.
  • Koren, Ronit; Shamir Medical Center. Department of Internal Medicine A. Zerifin. IL
  • Koren, Shlomit; Tel-Aviv University. Sackler Faculty of Medicine. Tel-Aviv. IL
  • Khashper, Alla; Tel-Aviv University. Sackler Faculty of Medicine. Tel-Aviv. IL
  • Benbassat, Carlos; Tel-Aviv University. Sackler Faculty of Medicine. Tel-Aviv. IL
  • Pekar-Zlotin, Marina; Tel-Aviv University. Sackler Faculty of Medicine. Tel-Aviv. IL
  • Vaknin, Zvi; Tel-Aviv University. Sackler Faculty of Medicine. Tel-Aviv. IL
Arch. endocrinol. metab. (Online) ; 65(6): 841-845, Nov.-Dec. 2021. tab, graf
Article in English | LILACS | ID: biblio-1350003
ABSTRACT
SUMMARY Ovarian adrenal rest tumors (OARTs) are very rare. We describe a case of a young woman with uncontrolled classical congenital adrenal hyperplasia (CCAH), presenting with bilateral OARTs, successfully treated with steroid replacement. A 20-year-old woman, known to have 21OH-CCAH, presented with severe abdominal pain, vomiting, diarrhea, and fever. As a result of poor compliance, 6 months before her admission hirsutism worsened and amenorrhea, hyperpigmentation, and weakness developed. ACTH levels were 278 < pmol/L and 17OHP 91.3 nmol/L. She was admitted for parenteral antibiotics and high-dose hydrocortisone treatment. CT revealed bilateral juxta-ovarian masses (6.2 x 3.6 x 7.4 cm left and 5 x 2.2 x 3.2 cm right) that on MRI were iso-intense in T1 and hypointense in T2, with early enhancement and rapid washout. One week of high-dose hydrocortisone resulted in significant clinical and laboratory improvement and the patient was discharged with 2 mg dexamethasone/day. One month later US revealed shrinkage of the masses and dexamethasone dose was decreased. At three months from discharge, she has resumed regular menses, and a repeated MRI revealed the para-ovarian masses have shrunk. One year after the diagnosis, the para-ovarian masses have shrunk more to 2.8 x 1.9 x 4.3 on the left and 2.1 x 0.9 x 1.2 on the right with less contrast enhancement in comparison to previous test possibly due to fibrotic changes of the tissue. OARTs are rare tumors with a poorly known natural history, and surgery has been the first option in the few reported cases. We demonstrate that medical treatment is a good alternative, leading to significant tumor shrinkage over a short period.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Adrenal Hyperplasia, Congenital / Adrenal Rest Tumor Limits: Female / Humans / Male Language: English Journal: Arch. endocrinol. metab. (Online) Journal subject: Endocrinology / Metabolism Year: 2021 Type: Article Affiliation country: Israel Institution/Affiliation country: Shamir Medical Center/IL / Tel-Aviv University/IL

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Adrenal Hyperplasia, Congenital / Adrenal Rest Tumor Limits: Female / Humans / Male Language: English Journal: Arch. endocrinol. metab. (Online) Journal subject: Endocrinology / Metabolism Year: 2021 Type: Article Affiliation country: Israel Institution/Affiliation country: Shamir Medical Center/IL / Tel-Aviv University/IL